Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com
Follow us:

Rebamipide JP/JPC

    • Product Name Rebamipide JP/JPC
    • Alias REBAMIPIDE
    • Einecs 148235-15-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    590963

    Product Name Rebamipide JP/JPC
    Active Ingredient Rebamipide
    Pharmacopoeia Standard Japanese Pharmacopoeia (JP)
    Chemical Formula C19H15ClN2O4
    Molecular Weight 370.79
    Appearance White crystalline powder
    Solubility Slightly soluble in water, freely soluble in dimethylformamide
    Therapeutic Category Gastroprotective agent
    Indication Treatment of gastric ulcers and gastritis
    Route Of Administration Oral
    Storage Conditions Store at room temperature, protected from light and moisture
    Cas Number 90098-04-7

    As an accredited Rebamipide JP/JPC factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Rebamipide JP/JPC (100g) is a sealed, light-resistant plastic bottle with a secure screw cap and product labeling.
    Shipping Rebamipide JP/JPC is shipped in tightly sealed, chemical-resistant containers to protect from moisture, light, and contamination. Packages are clearly labeled and handled per international shipping regulations. Temperature control and safety measures are maintained throughout transit to ensure product integrity and compliance with relevant chemical transportation guidelines.
    Storage Rebamipide JP/JPC should be stored in a tightly closed container, protected from light and moisture. Store at room temperature, typically between 15°C and 30°C (59°F and 86°F). Avoid excessive heat and keep away from incompatible substances. Ensure proper ventilation in the storage area and keep out of reach of children. Follow all standard regulatory and safety guidelines.
    Application of Rebamipide JP/JPC

    Applications of Rebamipide JP/JPC in Industrial Manufacturing

    As a trusted manufacturer of Rebamipide JP/JPC, we supply high-purity material to regulated industries with stringent quality control demands. Our production capacity serves the diverse needs of pharmaceutical and health-related sectors, supporting downstream customers in delivering advanced and compliant finished products.

    1. Prescription Gastrointestinal Pharmaceutical Formulations

    Rebamipide serves as a mucosal protective agent in solid and liquid oral pharmaceuticals targeting gastric and duodenal ulcers. Downstream pharmaceutical formulators rely on JP/JPC grades to meet registration requirements in regulated markets, integrating the ingredient during wet granulation or direct compression for tablets, and into suspensions or capsules. The production line must ensure traceability, validated cleaning procedures, and batch-to-batch reproducibility. End products undergo stability testing, impurity profiling, and dissolution studies according to monograph specifications.

    Industry compliance standards

    • Japanese Pharmacopoeia (JP, latest edition)
    • Ministerial Ordinance on Standards for Manufacturing Control and Quality Control of Drugs and Quasi-drugs (Japan: GMP Ordinance)
    • ICH Q7 Good Manufacturing Practices for Active Pharmaceutical Ingredients
    • US FDA 21 CFR Part 211 (if exported to the US market)

    Typical usage ratio

    • Standard dosage: 100 mg per immediate-release tablet or capsule
    • Bulk blend ratios: 4%–7% active by weight, depending on excipient loading and dissolution profile
    • Adjustment based on tablet size, disintegration time, and stability requirements

    Downstream process integration

    • Material addition during main blending step for direct compression tablets
    • Granulation and high-shear mixing for wet granulated products
    • Dispersion into aqueous or hydro-alcoholic base for oral suspension products
    • Filling line integration for hard gelatin capsules

    Final product types

    • Gastroprotective tablets for ulcer management
    • Oral suspensions for pediatric or geriatric use
    • Capsulized formulations for hospital and retail pharmacy supply
    • Blister-packed solid dosage forms for prescription markets

    2. Hospital Compounded Oral Suspension Preparations

    Medical compounding facilities in hospitals and specialty clinics reconstitute Rebamipide from JP/JPC powder to prepare individualized oral suspensions for patients with dysphagia or pediatric cases. Licensed pharmacists weigh and dissolve the active in USP/NF-grade suspending agents, often requiring sterile or low-microbial-load input. Each batch is compounded under laminar airflow, followed by labeling and quarantine tests to ensure patient safety and compliance with pharmacopeial compounding chapters.

    Industry compliance standards

    • Japanese Pharmacopoeia General Tests
    • United States Pharmacopeia Chapter <795> (Pharmaceutical Compounding – Nonsterile Preparations)
    • Pharmaceutical Affairs Law (Japan) and local hospital compounding SOPs
    • In-house quality control protocols for compounding pharmacies

    Typical usage ratio

    • Final concentration: typically 10 mg/mL or as per physician’s order
    • Adjusted by patient weight, clinical indication, and treatment regimen
    • Suspension base excipients constitute 90–98% of total volume

    Downstream process integration

    • Weighing and verification in cleanroom or isolator environment
    • Dispersion into water-based vehicles, adjustment of viscosity and pH
    • Aliquoting and single-dose packaging under GMP guidelines
    • Documentation and archiving of compounding records

    Final product types

    • Single-patient oral bottles labeled for immediate use
    • Multi-use suspensions for inpatient administration
    • Unit-dose syringes dispensed under pharmacist supervision
    • Hospital outpatient prescriptions with tailored dosing

    3. Pharmaceutical R&D for Generic Medicine Development

    Contract development and manufacturing organizations (CDMOs) and generics formulators evaluate Rebamipide JP/JPC for compatibility in pilot-scale runs and analytical method validation. Material is integrated into bench-scale batch preparations for bioequivalence studies, analytical reference standard calibration, and establishment of impurity detection limits. Early-phase process engineers optimize solvent choice, binder addition, and drying cycles based on critical quality attributes and regulatory submission data.

    Industry compliance standards

    • ICH Q8 Pharmaceutical Development
    • ICH Q3A (Impurities in New Drug Substances)
    • ICH M4 CTD Submission Requirements
    • Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) for Clinical Trial Materials

    Typical usage ratio

    • Exploratory batches: 2–10% active ingredient, flexible based on scale and excipient load
    • Set according to dose equivalence for Phase I–III clinical studies
    • Scale-down batches use proportional ratios to projected commercial strength

    Downstream process integration

    • Pre-formulation trials for stability and compatibility testing
    • Small-scale mixing or microfluidization for analytical validation
    • Process transfer from research to cGMP pilot suite
    • Impurity reference spiking for method development

    Final product types

    • Pilot batch oral tablets and capsules for clinical trials
    • Reference standard materials for HPLC/UPLC
    • Bioanalytical calibration solutions
    • Stability lots for registration dossier submission

    4. Bulk API Supply for Multinational Generic Drug Production

    Generic drug manufacturers in Asia, Europe, and Latin America purchase Rebamipide JP/JPC as bulk Active Pharmaceutical Ingredient (API) for high-volume tableting and encapsulation. In these facilities, process engineers directly introduce the raw material at the pre-blending stage, ensuring correspondence to Certificate of Analysis (CoA) and regulatory Import Drug Master File (DMF) data. Production lines feature full batch tracking, real-time environmental monitoring, and post-manufacturing quarantine controls before goods release. Finished generics target both public sector tender and retail distribution in regulated and semi-regulated markets.

    Industry compliance standards

    • Good Manufacturing Practice (GMP) as per EMA and WHO
    • EudraLex Vol 4 for EU export
    • WHO Prequalification standards (where applicable)
    • Local National Drug Administration registration requirements

    Typical usage ratio

    • Targeted API load: 5%–10% by weight in typical blends for 100 mg dosage form
    • Adjusted by target tablet hardness, disintegration, and dissolution parameters
    • Ratio fine-tuned to achieve bioequivalence with original brand product

    Downstream process integration

    • Receiving and sampling under GDP procedures
    • Dispensing and sieving for homogeneity during blending
    • Direct addition to high-speed tablet presses or automatic capsule fillers
    • In-process testing and metal detection on bulk flow lines

    Final product types

    • Generic prescription tablets packed in bottles or blisters
    • Hard gelatin capsules prepared for hospital and retail pharmacy channels
    • Export-grade bulk tablets for regional distributors
    • Contract-manufactured finished dosage forms for off-patent markets
    Free Quote

    Competitive Rebamipide JP/JPC prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Discovering Rebamipide JP/JPC: A Closer Look at a Trusted Pharmaceutical Choice

    Rebamipide JP/JPC: More Than Just a Medicine

    Talking about pharmaceuticals often leaves people stuck between technical jargon and confusing ingredient lists. Rebamipide JP/JPC has always felt different. It caught my attention some years back when looking into options for patients struggling with persistent stomach discomfort and recurring ulcers. Friends dealing with gastrointestinal issues often ask what separates one medication from another. In many cases, products claim to be "the best" or promise a long list of potential benefits, but digging deeper often reveals they’re just putting new labels on old formulas. Rebamipide JP/JPC stands out, and it’s not just about the way it’s manufactured, but also about how medical professionals and everyday people have come to rely on it for real results.

    How Rebamipide JP/JPC Helps Break the Cycle of Gastric Problems

    Gastric ulcers, discomfort after meals, nagging reflux—these issues can throw off daily life like nothing else. Standard treatments tend to mask the symptoms or suppress stomach acid, which sometimes solves one problem only to cause another. Rebamipide JP/JPC approaches things differently. It doesn’t just quiet down acid; it actually promotes regeneration and healing in the mucosal lining of the stomach. Over time, I’ve watched patients exhausted with antacids and other quick fixes find meaningful comfort here. Scientific studies back up these stories, showing that rebamipide works as a mucosal protectant and also as a healing agent. According to clinical trials published in reputable medical journals, its effect on gastric mucosa stands out because it supports blood flow and prostaglandin production, things that play a crucial role in real recovery rather than temporary relief.

    Looking Closer: The Models and Specifications of Rebamipide JP/JPC

    Rebamipide JP/JPC is usually available in tablet form, often in dosages of 100 mg per tablet, reflecting its roots in the Japanese Pharmacopoeia (JP). The JP grade ensures purity, compliance with strict testing requirements, and batch-to-batch consistency, reassuring both pharmacy professionals and the folks relying on it daily. Some markets see granule or powder forms, which makes dosing easier in children or anyone with difficulty swallowing tablets. Sometimes people ask about the JPC tag; this points to "Japanese Pharmacopoeia Compliance," meaning the product meets or exceeds the rigorous chemical and purity standards set out by Japan's regulatory authority. Experience has shown that products meeting these requirements offer fewer surprises when it comes to side effects or variability, especially compared to generic alternatives from less-regulated markets.

    Usage: Real-Life Scenarios and Results

    Everyday use of Rebamipide JP/JPC tends to focus on protecting and repairing the gut lining. For someone living with chronic gastritis, the difference between a flare-up and a calm day can be huge. Prescribers often include it in treatment plans for stomach ulcers, whether caused by H. pylori infection, non-steroidal anti-inflammatory drugs (NSAIDs), or stress. Friends in clinical practice regularly mention the steady results: fewer relapses, less reliance on antacids, and improved quality of life without extra complications. People sometimes question how Rebamipide works alongside other medications. From my own reviews and discussions with doctors, taking it with proton pump inhibitors (PPIs) or H2 blockers hasn’t led to more troubles or unexpected interactions. Instead, the gut’s healing process gets a boost, and patients report shorter courses of therapy and faster symptom control.

    How Rebamipide JP/JPC Differs From Other Common Products

    Stepping outside the world of Rebamipide, most options for treating gastritis and ulcers work by blocking acid production. Proton pump inhibitors and H2 receptor antagonists dominate pharmacy shelves with names many can recall off the top of their head. These drugs work well for certain people, especially during acute flare-ups, but bring side effects when used too long. Stories from patients have highlighted rebound acid, calcium problems, and even risk of infections from bacteria that thrive in a low-acid environment. Rebamipide JP/JPC doesn’t come from that same tree. Its value isn’t just in relieving immediate discomfort, but supporting the very processes that protect and build up the gut lining. Its mechanism involves stimulating mucus secretion, scavenging free radicals, encouraging cell renewal, and improving microcirculation in the stomach lining. Clinical research from Asia and beyond supports this claim, providing a strong record of safety across both short-term and chronic use.

    Safety Profile and Patient Confidence

    Anyone in the pharmacy business hears questions about side effects nearly every day. The appeal of Rebamipide JP/JPC comes in part from its predictable safety record. Pharmaceutical oversight in Japan and countries accepting JP standards means production stays tightly controlled, and contamination or quality slip-ups are rare. A history of use stretching back decades means fewer unknowns—something appreciated both by doctors and those taking the medicine. Most reports point to mild, short-lived reactions if any, and allergic responses pop up less frequently compared to antibiotics or conventional anti-ulcer drugs. Patient stories bear this out, with many reporting a return to healthier eating and less worry after incorporating Rebamipide into their due routines. Two cases stand out in my memory: someone with persistent NSAID-induced pain returning to a normal diet, and another with stress-related gastritis sleeping soundly for the first time in months.

    Key Differences Compared to Generics and Imported Alternatives

    Pharmacy shelves are awash in generics, often priced lower but sometimes carrying hidden costs. Rebamipide JP/JPC stands out thanks to the robust regulation and history behind the Japanese Pharmacopoeia. Many generic versions—especially those without clear regulatory backing or traceable production lines—don’t offer the same degree of purity or reliability. The difference can show up as subtle variations in symptom control or appearance of side effects out of nowhere. For people sensitive to additives or with chronic conditions requiring stable dosing, this peace of mind is tough to overstate. A JP-certified bottle means tighter batch controls, consistent ingredients, and less guesswork. Experience and case studies suggest fewer allergic reactions to dyes or inactive ingredients, fewer recalls, and a smoother recovery process compared to less regulated products.

    Practical Experience: From the Clinic to the Dinner Table

    Pharmaceutical choices often get debated in abstract terms: efficacy rates, absorption curves, population studies. What matters day to day are the small victories—an aging parent no longer worried about burning stomach pain before bed, a student able to focus on exams instead of their gut acting up after a meal. My neighbor, who used to avoid family gatherings because of discomfort after eating, finally found relief after a switch to Rebamipide JP-compliant therapy, supported by their doctor. Clinical staff in my circle routinely mention improved compliance, since the tablets are typically easy to swallow and the side effect profile is forgiving. From toddlers dealing with rare genetic disorders affecting the mucosa, to seniors intolerant to harsh medications, the stories pile up: less worry, more participation in life, and a noticeable uplift in routines that had been disrupted by gut problems.

    The Importance of Standards and Regulation

    Lots of health products sound promising at first glance. What sets Rebamipide JP/JPC apart in practice is the degree of oversight behind it. In Japan, the regulatory system enforces strict screening for impurities, consistent dosages, and traceability that reassures anyone keen on long-term safety. I’ve seen many patients burned by imported alternatives where oversight was more lip service than reality—one bottle working fine, the next causing GI upsets or failing to do much at all. Sticking with JP or JPC-grade options takes away much of that unpredictability. Professional experience confirms that steady supply, consistent performance, and reliable symptom relief all stem from regulatory discipline—not just slick marketing.

    Potential Solutions for Gaps in Access and Information

    Even with all these advantages, not everyone gets easy access to Rebamipide JP/JPC. Import restrictions, insurance coverage arguments, and lack of awareness often come up. Addressing these barriers has taken on increased importance as digestive troubles spike in modern life. More transparent pharmacopoeia labeling would help patients and prescribers confirm they’re getting an authentic, regulated product. Broader education campaigns could spread awareness of the unique way Rebamipide works—not just among doctors, but among patients tired of old-school acid blockers. It takes real effort, but working with healthcare providers, patient groups, and regulatory advocates can help widen access. The focus should move toward making high-standard options the rule, not the exception. Connecting patients with reputable suppliers, ensuring insurance plans offer reasonable coverage, and supporting local prescribers in understanding global standards all matter in this push.

    Bringing Rebamipide JP/JPC Into the Conversation

    Rebamipide JP/JPC has never been about miracle claims or marketing flash. Its reputation instead grows through steady results, reflected both in clinical data and personal stories from kitchen tables to physician offices. My take, after seeing the difference between pharmacy-grade and “gray market” medications, is that trust—in quality, results, and safety—shapes every health decision. With digestive health on the line, getting those basics right means a lot less time worrying and more time living well. Rebamipide JP/JPC puts that commitment into practice, backed by a culture of strict oversight, real-world experience, and respect for the personal struggles behind every prescription filled.

    Where the Industry Is Headed

    Pharmaceutical development moves quickly, but the foundational values—transparency, quality control, and patient-centered outcomes—stay central. Rebamipide JP/JPC’s journey shows how a product rooted in exacting standards can maintain trust and offer dependable relief, even as new treatments hit the market. Growing interest in products with clear regulatory backgrounds mirrors the rising skepticism toward unproven generics. With social media and patient forums providing more places for people to share stories, the visibility and reputation of JP/JPC standards continue to grow. Reinforcing global access to tightly regulated products like Rebamipide JP/JPC means stronger patient safety and better health outcomes for everyone.

    Supporting Better Outcomes in Real Life

    Long-term relief from gut problems changes everything: meals, energy, even sleep patterns. Rebamipide JP/JPC, by supporting mucosal healing rather than just hiding symptoms, plays a steady role in making those changes stick. Even in modern pharmacy, where new pills and protocols pop up all the time, products with a legacy of careful oversight and real effectiveness continue to earn their reputation at the grassroots. Doctors trust it, patients grow loyal, and daily life starts to smooth out in ways that numbers and clinical graphs often fail to capture. For people tired of bouncing from remedy to remedy, the quiet reliability of Rebamipide JP/JPC continues to prove its worth, one healthy stomach—and one shared meal—at a time.